{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:07:38Z","timestamp":1794442058402,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The major special project of science and technology for the construction of innovative provinces in Hunan Province","award":["2021SK1020"],"award-info":[{"award-number":["2021SK1020"]}]},{"name":"Suzhou Industrial Park Xinxin Cardiovascular Health Foundation Project","award":["2020-CCA-ACCESS-117"],"award-info":[{"award-number":["2020-CCA-ACCESS-117"]}]},{"name":"China international medical foundation 2021 Cardiovascular Multidisciplinary Integrated Thinking Research Fund Project","award":["z-2016-23-2101-20"],"award-info":[{"award-number":["z-2016-23-2101-20"]}],"id":[{"id":"https:\/\/ror.org\/03hy6ga56","id-type":"ROR","asserted-by":"crossref"}]},{"name":"China international medical foundation 2021 Cardiovascular Multidisciplinary Integrated Thinking Research Fund Project","award":["z-2019-42-1908-3"],"award-info":[{"award-number":["z-2019-42-1908-3"]}],"id":[{"id":"https:\/\/ror.org\/03hy6ga56","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Hunan Province Health Commission","award":["202203014687"],"award-info":[{"award-number":["202203014687"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chronic inflammation and dyslipidemia are important risk factors in developing atherosclerotic cardiovascular disease, such as coronary heart disease. Acute coronary syndrome (ACS) is one of the most dangerous syndromes in coronary heart disease. Type 2 diabetes mellitus (T2DM) is considered equal to coronary heart disease owing to the high cardiac risk induced by chronic inflammation and dyslipidemia. The neutrophil to high-density lipoprotein cholesterol ratio (NHR) is a novel and straightforward marker that reflects inflammation and lipid metabolic disorder. However, few studies have been on the role of NHR in assessing the risk of ACS in T2DM patients. Here we analyzed NHR level in ACS patients with T2DM, exploring its predictive and diagnostic values. 211 hospitalized ACS patients with T2DM were recruited as the case group, and 168 hospitalized T2DM patients as the control group (all patients collected from 6\/2020 to 12\/2021 in Xiangya Hospital). Biochemical test results and echocardiograms, as well as demographic information such as age, BMI, diabetes mellitus, smoking, drinking, and history of hypertension, were recorded. Frequencies, percentages, means, and standard deviations were used to describe the data. The shapiro\u2013Wilk test was used to assess the normality of the data. Normally distributed data were compared using the independent sample T-test, and non-normally distributed data were compared using Mann\u2013Whitney U test. Correlation analysis was performed using the Spearman rank correlation test, and receiver operating characteristic (ROC) curve analysis and multivariable logistic regression analysis were performed by SPSS version 24.0 (SPSS Inc) and GraphPad Prism 9.0 (GraphPad Software Inc).\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05 was considered significant. In the study population, NHR was higher in patients with T2DM combined with ACS than in T2DM patients without ACS (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). After adjusting for BMI, alcohol consumption, and history of hypertension, multifactorial logistic regression analysis revealed that NHR is a risk factor for T2DM patients combined with ACS (OR 1.221,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0126). Correlation analysis on all ACS patients with T2DM showed that NHR level was positively correlated with cTnI (r\u2009=\u20090.437,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), CK (r\u2009=\u20090.258,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001), CK-Mb (r\u2009=\u20090.447,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), LDH (r\u2009=\u2009384,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), Mb (r\u2009=\u20090.320,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), LA (r\u2009=\u20090.168,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.042) and LV levels (r\u2009=\u20090.283,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). And meanwhile, NHR level was negatively correlated with EF (r\u2009=\u2009\u2212\u20090.327,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and FS levels (r\u2009=\u2009\u2212\u20090.347,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). ROC curve analysis showed that NHR\u2009\u2267\u20094.32 had a sensitivity of 65.45% and a specificity of 66.19% for predicting ACS in T2DM patients [area under the curve (AUC)\u2009=\u20090.722,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001]. Furthermore, in all ACS patients with T2DM, the diagnostic power of NHR was stronger in ST-segment elevated ACS patients (STE-ACS) than that in non-ST-segment elevated ACS patients (NSTE-ACS) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt; 0.001). With its convenience and effective character, NHR could be a potential and new marker for predicting the presence, progression, and severity of ACS in T2DM population.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-35050-6","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:14:57Z","timestamp":1684138497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study"],"prefix":"10.1038","volume":"13","author":[{"given":"Hao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sayed","family":"Ali Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"9","key":"35050_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu, Y. et al. Prevalence and control of diabetes in Chinese adults. JAMA 310(9), 948\u2013959 (2013).","journal-title":"JAMA"},{"issue":"6","key":"35050_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","volume":"61","author":"RCW Ma","year":"2018","unstructured":"Ma, R. C. W. Epidemiology of diabetes and diabetic complications in China. Diabetologia 61(6), 1249\u20131260 (2018).","journal-title":"Diabetologia"},{"issue":"1","key":"35050_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson, T. R., Acs, A., Ludwig, C. & Panton, U. H. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc. Diabetol. 17(1), 83 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"35050_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-018-0793-x","volume":"17","author":"M Zhou","year":"2018","unstructured":"Zhou, M. et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: Findings from the improving care for cardiovascular disease in china-acute coronary syndrome project. Cardiovasc. Diabetol. 17(1), 147 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"13","key":"35050_CR5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/eurheartj\/ehq162","volume":"31","author":"R De Caterina","year":"2010","unstructured":"De Caterina, R., Madonna, R., Sourij, H. & Wascher, T. Glycaemic control in acute coronary syndromes: Prognostic value and therapeutic options. Eur. Heart J. 31(13), 1557\u20131564 (2010).","journal-title":"Eur. Heart J."},{"key":"35050_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5153","volume":"351","author":"A Timmis","year":"2015","unstructured":"Timmis, A. Acute coronary syndromes. BMJ 351, h5153 (2015).","journal-title":"BMJ"},{"issue":"7","key":"35050_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt, D. L., Lopes, R. D. & Harrington, R. A. Diagnosis and treatment of acute coronary syndromes: A review. JAMA 327(7), 662\u2013675 (2022).","journal-title":"JAMA"},{"issue":"4","key":"35050_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jcmg.2017.06.023","volume":"12","author":"S Farhan","year":"2019","unstructured":"Farhan, S. et al. Impact of pre-diabetes on coronary plaque composition and clinical outcome in patients with acute coronary syndromes: An analysis from the PROSPECT study. JACC Cardiovasc. Imaging 12(4), 733\u2013741 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"16","key":"35050_CR9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352(16), 1685\u20131695 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"35050_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jacbts.2017.07.001","volume":"2","author":"JA Rymer","year":"2017","unstructured":"Rymer, J. A. & Newby, L. K. Failure to launch: Targeting inflammation in acute coronary syndromes. JACC Basic Transl. Sci. 2(4), 484\u2013497 (2017).","journal-title":"JACC Basic Transl. Sci."},{"issue":"6","key":"35050_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","volume":"110","author":"O Soehnlein","year":"2012","unstructured":"Soehnlein, O. Multiple roles for neutrophils in atherosclerosis. Circ. Res. 110(6), 875\u2013888 (2012).","journal-title":"Circ. Res."},{"issue":"3","key":"35050_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/eci.12566","volume":"46","author":"A Pende","year":"2016","unstructured":"Pende, A., Artom, N., Bertolotto, M., Montecucco, F. & Dallegri, F. Role of neutrophils in atherogenesis: An update. Eur. J. Clin. Invest. 46(3), 252\u2013263 (2016).","journal-title":"Eur. J. Clin. Invest."},{"issue":"23 Suppl 1","key":"35050_CR13","first-page":"8","volume":"109","author":"G Assmann","year":"2004","unstructured":"Assmann, G. & Gotto, A. M. Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 109(23 Suppl 1), 8\u201314 (2004).","journal-title":"Circulation"},{"issue":"1","key":"35050_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/cvr\/cvt169","volume":"100","author":"M Gomaraschi","year":"2013","unstructured":"Gomaraschi, M. et al. Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. Cardiovasc. Res. 100(1), 36\u201343 (2013).","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"35050_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","volume":"31","author":"AJ Murphy","year":"2011","unstructured":"Murphy, A. J. et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb. Vasc. Biol. 31(6), 1333\u20131341 (2011).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"35050_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.807339","volume":"9","author":"M Jiang","year":"2022","unstructured":"Jiang, M. et al. Prognostic role of neutrophil to high-density lipoprotein cholesterol ratio for all-cause and cardiovascular mortality in the general population. Front. Cardiovasc. Med. 9, 807339 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"35050_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-020-01238-2","volume":"19","author":"JB Huang","year":"2020","unstructured":"Huang, J. B. et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: A comparison study. Lipids Health Dis. 19(1), 59 (2020).","journal-title":"Lipids Health Dis."},{"issue":"9","key":"35050_CR18","first-page":"3179","volume":"26","author":"F Ba\u015fyi\u011fit","year":"2022","unstructured":"Ba\u015fyi\u011fit, F. & \u00c7\u00f6teli, C. Relationship between the neutrophil to HDL-C ratio and anatomical significance of coronary artery stenosis in patients with documented myocardial ischemia. Eur. Rev. Med. Pharmacol. Sci. 26(9), 3179\u20133184 (2022).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"24","key":"35050_CR19","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A. et al. 2014 AHA\/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 64(24), e139\u2013e228 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"35050_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cvr\/cvw024","volume":"110","author":"Y Ma","year":"2016","unstructured":"Ma, Y. et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc. Res. 110(1), 51\u201361 (2016).","journal-title":"Cardiovasc. Res."},{"key":"35050_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2019.00191","volume":"10","author":"JW Chen","year":"2019","unstructured":"Chen, J. W. et al. The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of carotid intima-media thickness in patients with type 2 diabetes. Front. Endocrinol. (Lausanne) 10, 191 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"21","key":"35050_CR22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.21037\/atm-21-4876","volume":"9","author":"C Li","year":"2021","unstructured":"Li, C. et al. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann. Transl. Med. 9(21), 1627 (2021).","journal-title":"Ann. Transl. Med."},{"key":"35050_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727419","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Prognostic value of leucocyte to high-density lipoprotein-cholesterol ratios in COVID-19 Patients and the diabetes subgroup. Front. Endocrinol. (Lausanne) 12, 727419 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"35050_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13386","volume":"51","author":"G Dong","year":"2021","unstructured":"Dong, G., Huang, A. & Liu, L. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis. Eur. J. Clin. Invest. 51(3), e13386 (2021).","journal-title":"Eur. J. Clin. Invest."},{"key":"35050_CR25","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2147\/DMSO.S219363","volume":"12","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab. Syndr. Obes. 12, 2117\u20132123 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"6","key":"35050_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3403","volume":"37","author":"I Jialal","year":"2021","unstructured":"Jialal, I., Jialal, G. & Adams-Huet, B. The platelet to high density lipoprotein-cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes Metab. Res. Rev. 37(6), e3403 (2021).","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"35050_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2215\/CJN.08730816","volume":"12","author":"TI Chang","year":"2017","unstructured":"Chang, T. I. et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol. 12(4), 591\u2013602 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"35050_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/10408398.2020.1764487","volume":"61","author":"F Gomez-Delgado","year":"2021","unstructured":"Gomez-Delgado, F., Katsiki, N., Lopez-Miranda, J. & Perez-Martinez, P. Dietary habits, lipoprotein metabolism and cardiovascular disease: From individual foods to dietary patterns. Crit. Rev. Food Sci. Nutr. 61(10), 1651\u20131669 (2021).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"9","key":"35050_CR29","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/ATVBAHA.110.209296","volume":"30","author":"MG Ionita","year":"2010","unstructured":"Ionita, M. G. et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb. Vasc. Biol. 30(9), 1842\u20131848 (2010).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"35050_CR30","doi-asserted-by":"crossref","unstructured":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 285(19), 2486\u20132497 (2001).","DOI":"10.1001\/jama.285.19.2486"},{"issue":"9","key":"35050_CR31","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/art.38703","volume":"66","author":"CK Smith","year":"2014","unstructured":"Smith, C. K. et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: An additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis Rheumatol. (Hoboken, NJ) 66(9), 2532\u20132544 (2014).","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"issue":"10","key":"35050_CR32","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","volume":"45","author":"BD Horne","year":"2005","unstructured":"Horne, B. D. et al. Which white blood cell subtypes predict increased cardiovascular risk?. J. Am. Coll. Cardiol. 45(10), 1638\u20131643 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"35050_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2012.04.012","volume":"224","author":"B \u00f3 Hartaigh","year":"2012","unstructured":"\u00f3 Hartaigh, B. et al. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis 224(1), 161\u2013169 (2012).","journal-title":"Atherosclerosis"},{"issue":"8","key":"35050_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani, A., Cassatella, M. A., Costantini, C. & Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11(8), 519\u2013531 (2011).","journal-title":"Nat. Rev. Immunol."},{"issue":"18","key":"35050_CR35","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2016-01-688887","volume":"127","author":"C Silvestre-Roig","year":"2016","unstructured":"Silvestre-Roig, C., Hidalgo, A. & Soehnlein, O. Neutrophil heterogeneity: Implications for homeostasis and pathogenesis. Blood 127(18), 2173\u20132181 (2016).","journal-title":"Blood"},{"issue":"1","key":"35050_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/JLB.4MIR0220-574RR","volume":"108","author":"C Rosales","year":"2020","unstructured":"Rosales, C. Neutrophils at the crossroads of innate and adaptive immunity. J. Leukoc Biol. 108(1), 377\u2013396 (2020).","journal-title":"J. Leukoc Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35050-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:26:23Z","timestamp":1684139183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35050"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35050-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7836"}}